.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
US Department of Justice
Julphar
Colorcon
Moodys
McKesson
Argus Health
AstraZeneca
Accenture
US Army

Generated: November 20, 2017

DrugPatentWatch Database Preview

Aton Company Profile

« Back to Dashboard

What is the competitive landscape for ATON, and what generic and branded alternatives to ATON drugs are available?

ATON has nine approved drugs.



Summary for Aton

US Patents:0
Tradenames:8
Ingredients:8
NDAs:9
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aton
TIMOPTIC IN OCUDOSE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC019463-002Nov 5, 1986RXYesYes► Subscribe► Subscribe► Subscribe
Aton
CUPRIMINE
penicillamine
CAPSULE;ORAL019853-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Aton Pharma Vpna
DEMSER
metyrosine
CAPSULE;ORAL017871-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Aton
LACRISERT
hydroxypropyl cellulose
INSERT;OPHTHALMIC018771-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Aton
CUPRIMINE
penicillamine
CAPSULE;ORAL019853-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Aton
EDECRIN
ethacrynic acid
TABLET;ORAL016092-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Aton
EDECRIN
ethacrynate sodium
INJECTABLE;INJECTION016093-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Aton
TIMOPTIC IN OCUDOSE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC019463-001Nov 5, 1986RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Aton

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Aton
LODOSYN
carbidopa
TABLET;ORAL017830-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Aton
TIMOPTIC IN OCUDOSE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC019463-001Nov 5, 1986► Subscribe► Subscribe
Aton
TIMOPTIC IN OCUDOSE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC019463-002Nov 5, 1986► Subscribe► Subscribe
Aton
TIMOPTIC IN OCUDOSE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC019463-002Nov 5, 1986► Subscribe► Subscribe
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Aton
TIMOPTIC IN OCUDOSE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC019463-001Nov 5, 1986► Subscribe► Subscribe
Aton
LODOSYN
carbidopa
TABLET;ORAL017830-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Medtronic
Baxter
Chinese Patent Office
Moodys
Chubb
Colorcon
Harvard Business School
Covington
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot